Efficacy of artemether-lumefantrine as a treatment for uncomplicated Plasmodium vivax malaria in eastern Sudan

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Abdallah, Tajeldin M ^a   Ali, Abdel Aziem A ^a   Bakri, Mohammed ^a   Gasim, Gasim I ^a,c   Musa, Imad R ^a,d   Adam, Ishag ^b  

^a University of Kassala   (Sudan)

^b UNIVERSITY OF KHARTOUM   (Sudan)

^c QASSIM UNIVERSITY   (Saudi Arabia)

^d Buraidah Central Hospital ^*  (Saudi Arabia)

Author keywords

Artemether lumefantrine; Efficacy; Malaria; P. vivax; Sudan.

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; DIZZINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; NAUSEA; OBSERVATIONAL STUDY; PLASMODIUM VIVAX MALARIA; PRESCHOOL CHILD; RASH; SCHOOL CHILD; SUDAN; TABLET; TREATMENT DURATION; TREATMENT RESPONSE; VOMITING; DRUG COMBINATION; DRUG EFFECT; MIDDLE AGED; PLASMODIUM VIVAX; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; MALARIA, VIVAX; MALE; MIDDLE AGED; PLASMODIUM VIVAX; SUDAN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84870382741     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-404     Document Type: Article

References (29)

1. The international limits and population at risk of Plasmodium vivax transmission in 2009. Guerra CA, Howes RE, Patil AP, Gething PW, Van Boeckel TP, Temperley WH, Kabaria CW, Tatem AJ, Manh BH, Elyazar IR, Baird JK, Snow RW, Hay SI, PLoS Negl Trop Dis 2010 4 774 10.1371/journal.pntd.0000774 20689816
2. The neglected burden of Plasmodium vivax malaria. Mendis K, Sina BJ, Marchesini P, Carter R, Am J Trop Med Hyg 2001 64 97 106 11425182
3. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, Alonso PL, del Portillo HA, Lancet Infect Dis 2009 9 555 566 10.1016/S1473-3099(09)70177-X 19695492
4. Confirmed vivax resistance to chloroquine and effectiveness of artemether-lumefantrine for the treatment of vivax malaria in Ethiopia. Yohannes AM, Teklehaimanot A, Bergqvist Y, Ringwald P, Am J Trop Med Hyg 2011 84 137 140 10.4269/ajtmh.2011.09-0723 21212216
5. Plasmodium vivax and P. falciparum epidemiology in Gambella, south-west Ethiopia. Nigatu W, Abebe M, Dejene A, Trop Med Parasitol 1992 43 181 185 1470839
6. Ethiopia Malaria Indicator Survey Working Group: Malaria indicator survey 2007 Ethiopia: coverage and use of major malaria prevention and control interventions. Jima D, Getachew A, Bilak H, Steketee RW, Emerson PM, Graves PM, Gebre T, Reithinger R, Hwang J, Malar J 2010 9 58 10.1186/1475-2875-9-58 20178654
7. Febrile illnesses of different etiology among outpatients in four health centers in Northwestern Ethiopia. Animut A, Mekonnen Y, Shimelis D, Ephraim E, J Infect Dis 2009 62 107 110
8. Severe Plasmodium vivax malaria among Sudanese children at New Halfa Hospital Eastern Sudan. Mahgoub H, Gasim GI, Musa IR, Adam I, Parasit Vectors 2012 5 154 10.1186/1756-3305-5-154 22846165
9. The burden of malaria in Sudan: incidence, mortality and disability-adjusted life-years. Abdalla SI, Malik EM, Ali KM, Malar J 2007 6 97 10.1186/1475-2875-6-97 17662153
10. Dihydroartemisinin-piperaquine versus artemether-lumefantrine, in the treatment of uncomplicated Plasmodium falciparum malaria in central Sudan. Adam I, Salah MT, Eltahir HG, Elhassan AH, Elmardi KA, Malik EM, Ann Trop Med Parasitol 2010 104 319 326 10.1179/136485910X12743554760144 20659392
11. Efficacies of chloroquine, sulphadoxine-pyrimethamine and quinine for the treatment of uncomplicated Plasmodium falciparum malaria in eastern Sudan. Adam I, Osman ME, Elghazali G, Ahmed GI, Gustafson LL, Elbashir MI, Ann Trop Med Parasitol 2004 98 661 666 10.1179/000349804225021514 15509420
12. World Health Organization, Implementation of the Global Malaria Control Strategy. Report of a WHO Study Group on the Implementation of the Global Plan of Action for Malaria Control 1993-2000. Technical Report Series no. 839 World Health Organization, Geneva 1993
13. The use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malaria. Quique B, PLoS Negl Trop Dis 2011 12 1325
14. Plasmodium vivax resistance to chloroquine? Rieckmann KH, Davis DR, Hutton DC, Lancet 1989 2 1183 1184 2572903
15. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Price RN, Douglas NM, Anstey NM, Curr Opin Infect Dis 2009 22 430 435 10.1097/QCO.0b013e32832f14c1 19571748
16. Artemisinin combination therapy for vivax malaria. Douglas NM, Anstey NM, Angus BJ, Nosten F, Price RN, Lancet Infect Dis 2010 10 405 416 10.1016/S1473-3099(10)70079-7 20510281
17. From chloroquine to artemisinin-based combination therapy: the Sudanese experience. Malik EM, Mohamed TA, Elmardi KA, Mowien RM, Elhassan AH, Elamin SB, Mannan AA, Ahmed ES, Malar J 2006 5 6 10.1186/1475-2875-5-6 16445865
18. Informed decision-making before changing to RDT: a comparison of microscopy, rapid diagnostic test and molecular techniques for the diagnosis and identification of malaria parasites in Kassala, eastern Sudan. Osman MM, Nour BY, Sedig MF, De Bes L, Babikir AM, Mohamedani AA, Mens PF, Trop Med Int Health 2010 15 1442 1448 10.1111/j.1365-3156.2010.02659.x 20973878
19. WHO, Methods for surveillance of antimalarial drug efficacy WHO.Int/Publications/ 2009 http://www.who.int/malaria/publications/atoz/ 9789241597531/en/index.html
20. Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine- pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial. Sagara I, Rulisa S, Mbacham W, Adam I, Sissoko K, Maiga H, Traore OB, Dara N, Dicko YT, Dicko A, Djimdé A, Jansen FH, Doumbo OK, Malar J 2009 8 63 10.1186/1475-2875-8-63 19366448
21. Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan. Elamin SB, Malik EM, Abdelgadir T, Khamiss AH, Mohammed MM, Ahmed ES, Adam I, Malar J 2005 4 41 10.1186/1475-2875-4-41 16162284
22. Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit,Ethiopia. Teka H, Petros B, Yamuah L, Tesfaye G, Elhassan I, Muchohi S, Kokwaro G, Aseffa A, Engers H, Malar J 2008 7 220 10.1186/1475-2875-7-220 18959774
23. Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand. Krudsood S, Tangpukdee N, Muangnoicharoen S, Thanachartwet V, Luplertlop N, Srivilairit S, Wilairatana P, Kano S, Ringwald P, Looareesuwan S, Korean J Parasitol 2007 45 111 114 10.3347/kjp.2007.45.2.111 17570973
24. Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia. Alvarez G, Piñeros JG, Tobón A, Ríos A, Maestre A, Blair S, Carmona-Fonseca J, Am J Trop Med 2006 76 605 609
25. Efficacy and safety of chloroquine for treatment in patients with uncomplicated Plasmodium vivax infections in endemic countries. Naing C, Aung K, Win DK, Wah MJ, Trans R Soc Trop Med 2010 104 695 705 10.1016/j.trstmh.2010.08. 009
26. Chloroquine resistance in Plasmodium vivax. Baird JK, Antimicrob Agents Chemother 2004 48 4075 4083 10.1128/AAC.48.11.4075-4083.2004 15504824
27. Resistance to therapies for infection by Plasmodium vivax. Baird JK, Clin Microbiol Rev 2009 22 508 534 10.1128/CMR.00008-09 19597012
28. Evaluation of chloroquine therapy for vivax and falciparum malaria in southern Sumatra, western Indonesia. Sutanto I, Endawati D, Ling LH, Laihad F, Setiabudy R, Baird JK, Malar J 2010 9 52 10.1186/1475-2875-9-52 20152016
29. Chloroquine-resistant Plasmodium vivax malaria in Serbo town, Jimma zone, south-west Ethiopia. Ketema T, Bacha K, Birhanu T, Petros B, Malar J 2009 8 177 10.1186/1475-2875-8-177 19642976